Daily Pharma News #Pfizer #aurobindopharma #Alembic #Agilus #Bayer #Sanofi #USFDA #HealthcareNews

🚨 Pharma News Today | Daily Pharma Industry Updates by Pharma Datum

In today's top pharmaceutical industry updates:

💉 Pfizer presents positive Phase 2b study results for its GLP-1 receptor agonist candidate berobenatide at the 86th ADA Scientific Sessions.

✅ Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets.

🤝 Alembic Pharma announces acquisition of a 45% stake in a Canadian venture.

🧬 Agilus Diagnostics launches the Idylla system, enabling cancer mutation test results in as little as 3 hours.

📈 Bayer announces key leadership changes within its Consumer Health division to support future growth.

🌍 Sanofi's Sarclisa subcutaneous formulation receives European Union approval as the first anticancer therapy delivered via an on-body injector.

🏢 Barentz expands its North American footprint with a new pharmaceutical office to strengthen local partnerships and customer support.

Stay updated with the latest pharmaceutical industry news, US FDA approvals, oncology innovations, GLP-1 developments, diagnostics technology, pharma investments, and global healthcare business updates.

Pharma Datum connects pharmaceutical and chemical businesses through sourcing, supplier discovery, surplus inventory solutions, and industry intelligence.

🔔 Subscribe to Pharma Datum for daily pharma news and industry updates.

#PharmaNews #Pfizer #AurobindoPharma #AlembicPharma #AgilusDiagnostics #Bayer #Sanofi #Barentz #USFDA #PharmaDatum

Видео Daily Pharma News #Pfizer #aurobindopharma #Alembic #Agilus #Bayer #Sanofi #USFDA #HealthcareNews канала Pharma Datum